Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
2021 · World Journal of Surgical Oncology · 17 citations
https://doi.org/10.1186/s12957-021-02192-8
T
Takayuki Shiraki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
433
Citations
13
h-index
18
i10-index
Takayuki Shiraki is an academic researcher from Dokkyo Medical University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 13, co-authored 61 publications.
ORCID: 0000-0003-2935-6708Papers by this author
worksClinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma
2020 · World Journal of Surgical Oncology · 13 citations
https://doi.org/10.1186/s12957-020-01900-0
Glycated albumin suppresses glucose-induced insulin secretion by impairing glucose metabolism in rat pancreatic β-cells
2011 · Nutrition & Metabolism · 12 citations
https://doi.org/10.1186/1743-7075-8-20
Is left-sided involvement of hepatocellular carcinoma an important preoperative predictive factor of poor outcome?
2020 · World Journal of Surgical Oncology · 10 citations
https://doi.org/10.1186/s12957-020-02100-6
Micro-hepatocellular carcinoma with bile duct tumor thrombus mimicking intrahepatic intraductal papillary neoplasm of the bile duct: a case report
2023 · Surgical Case Reports · 0 citations
https://doi.org/10.1186/s40792-023-01646-3
A resected case of pancreatic head cancer developing 40 years after lateral pancreaticojejunostomy for chronic pancreatitis
2024 · Clinical Journal of Gastroenterology · 0 citations
https://doi.org/10.1007/s12328-024-01924-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat